Tools for clinical pharmacists to identify medications that can cause drug-induced cognitive impairment: A systematic review

被引:0
|
作者
Stanton, Jacob [1 ]
Gionfriddo, Michael R. [2 ]
Rattinger, Gail B. [3 ]
Fang, Yuan [3 ]
Lussier, Mia E. [4 ]
机构
[1] Binghamton Univ, Sch Pharm & Pharmaceut Sci, Binghamton, NY USA
[2] Duquesne Univ, Sch Pharm, Div Pharmaceut Adm & Social Sci, Pittsburgh, PA USA
[3] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Binghamton, NY USA
[4] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Dept Pharm Practice, Binghamton, NY 13902 USA
关键词
adverse effects; cognitive dysfunction; potentially inappropriate medications; ANTICHOLINERGIC DRUGS; RISK;
D O I
10.1002/jac5.2049
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cognitive impairment affects around 19% of community-dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive-impairing medications through cognitive-focused medication reviews or as part of comprehensive medication management. Multiple tools exist to help pharmacists and other practitioners identify these medications, yet a comprehensive description of these tools has not been undertaken. We searched EBSCO MEDLINE, PubMed, EMBASE, CINAHL, and PsycInfo from inception to August 4, 2023, using search terms relative to medications and cognition. Studies were included if they detailed a tool to assess the cognitive burden of a medication regimen. Abstracts and full texts were screened independently and in duplicate. Any disagreements at the level of full-text screening were resolved by consensus. Eligible studies underwent data extraction by two authors independently and in duplicate using a data extraction form. Our search identified 13 126 articles of which only four tools were initially included. Additionally, we identified seven articles from the reference lists of excluded review articles for a final inclusion count of 11 tools. Articles were published between 2001 and 2017. Nine of 11 tools (82%) were focused solely on anticholinergic medications, while only one tool indicated a clinically relevant cutoff value and alternative medication recommendations. While there are many tools to assess the cognitive burden from medications, many are limited by the development date, focus on anticholinergic medications, or lack clinically useful information. Further research is needed to develop more comprehensive, up-to-date, and readily implementable tools that clinical pharmacists can utilize to assess medication-induced cognitive risks. Such as tool could be applied by pharmacists in many settings to optimize medication use and improve patient outcomes.
引用
收藏
页码:1207 / 1227
页数:21
相关论文
共 50 条
  • [21] DRUG-INDUCED COGNITIVE IMPAIRMENT - DEFINING THE PROBLEM AND FINDING SOLUTIONS
    BOWEN, JD
    LARSON, EB
    DRUGS & AGING, 1993, 3 (04) : 349 - 357
  • [22] Drug-induced cognitive impairment in geriatric assessment clinic patients
    Ranno, AE
    Potter, JF
    Morton, JL
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (09) : P208 - P208
  • [23] Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction
    Montgomery, SA
    Baldwin, DS
    Riley, A
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 69 (1-3) : 119 - 140
  • [24] Subjective emotional experience and cognitive impairment in drug-induced akathisia
    Kim, JH
    Lee, BC
    Park, HJ
    Ahn, YM
    Kang, UG
    Kim, YS
    COMPREHENSIVE PSYCHIATRY, 2002, 43 (06) : 456 - 462
  • [25] Drug-Induced Pityriasis Rosea: A Systematic Review
    Devoy, Chloe
    Lee, Andy
    Geng, Ryan S. Q.
    Rijal, Hibo
    Han, Jing Yi
    Wilken, Bethany
    Chen, Jennifer
    Bouadi, Naila
    Sibbald, Cathryn
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [27] Drug-Induced Cerebellar Ataxia: A Systematic Review
    van Gaalen, J.
    Kerstens, F. G.
    Maas, R. P. P. W. M.
    Harmark, L.
    van de Warrenburg, B. P. C.
    CNS DRUGS, 2014, 28 (12) : 1139 - 1153
  • [28] Drug-induced thrombocytopenia: An updated systematic review
    Li, XN
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (06) : 474 - 475
  • [29] Drug-induced thrombocytopenia: An updated systematic review
    Rizvi, MA
    Kojouri, K
    George, JN
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (04) : 346 - 346
  • [30] Drug-induced alopecia areata: A systematic review
    Ezemma, Ogechi
    Devjani, Shivali
    Jothishankar, Balaji
    Kelley, Kristen J.
    Senna, Maryanne
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 133 - 134